Trial Profile
Tolerability and efficacy of Exenatide relative to basal insulin according to race in patients with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Dec 2017
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 20 Dec 2017 New trial record
- 01 Dec 2017 Results published in the Diabetes Therapy